Evaluation of Local Response of Prostate Cancer to Irradiation Using Multiparametric MRI and MR-Guided Biopsies
Demographics (2)
- AGE - Subject age at enrollment (phv00407169.v1.p1)
- SEX - Biological sex (phv00570542.v1.p1)
Disease Events (1)
- PSA - Baseline PSA at time of diagnosis (phv00407167.v1.p1)
Race and Ethnicity (1)
- RACE - Self-reported race (phv00407172.v1.p1)
Other (16)
- AFFECTION_STATUS - Case control status of the subject for prostate cancer (phv00407164.v1.p1)
- ANALYTE_TYPE - Analyte Type (phv00407175.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00407174.v1.p1)
- CONSENT - Registered consent groups (Data Use Limitations (DUL)) as determined by submitters' Institutional Review Boards (IRB) or equivalent body (phv00407160.v1.p1)
- FOCI_ID - Tumor foci block number(s) identifier (phv00407178.v1.p1)
- GLEASON_SCORE - Gleason score at diagnosis (phv00407168.v1.p1)
- GLEASON_SCORE - Gleason score of tumor sample (phv00407177.v1.p1)
- IS_TUMOR - Tumor status (phv00407176.v1.p1)
- NCCN_RISK_GROUP - Risk group according ot the NCCN (phv00407170.v1.p1)
- SAMPLE_ID - Sample ID (phv00407173.v1.p1)
- SAMPLE_ID - Sample ID (phv00407162.v1.p1)
- STUDY_ID - Identifier used in publication (phv00407165.v1.p1)
- SUBJECT_ID - Subject ID (phv00407163.v1.p1)
- SUBJECT_ID - Subject ID (phv00407159.v1.p1)
- SUBJECT_ID - Subject ID (phv00407161.v1.p1)
- T_STAGE - Clinical T Stage (phv00407171.v1.p1)